2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Cerrone Gabriel | — | 5,183,579 | Aug 17, 2016 |
| Garlikov Donald E | — | 3,320,000 | Apr 2, 2019 |
| Cavan John T | CFO | 1,200,000 | May 20, 2021 |
| Sapirstein James | CEO | 492,819 | Jan 5, 2018 |
| Lippa Arnold | — | 200,000 | May 20, 2021 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Mar 7, 2024 | Purcell Michael J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 6, 2024 | Purcell Michael J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 19, 2024 | Feb 21, 2024 | Block Timothy M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 19, 2024 | Feb 21, 2024 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 19, 2024 | Feb 21, 2024 | Lbiati Kaouthar | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 19, 2024 | Feb 21, 2024 | BRANCACCIO JOHN P | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 24, 2023 | Nov 28, 2023 | Wijngaard Peter | Director | Buy | 91.3 | +5,000 | 111.09% | ✗ | $15.4K |
| Sep 15, 2023 | Sep 20, 2023 | Wijngaard Peter | Director | Buy | 91.3 | +3,000 | 199.87% | ✗ | $16.8K |
| Sep 18, 2023 | Sep 19, 2023 | Foster Robert T | CEO | Buy | 82.5 | +1,600 | 3.27% | ✗ | $9K |
| Sep 15, 2023 | Sep 18, 2023 | Foster Robert T | CEO | Buy | 82.5 | +1,600 | 3.38% | ✗ | $8.6K |
| Jul 20, 2022 | Lbiati Kaouthar | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 5, 2022 | Reddi Anand | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 18, 2021 | May 20, 2021 | Lippa Arnold | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 18, 2021 | May 20, 2021 | Wijngaard Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 18, 2021 | May 20, 2021 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 18, 2021 | May 20, 2021 | Foster Robert T | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 18, 2021 | May 20, 2021 | Cavan John T | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 18, 2021 | May 20, 2021 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 18, 2021 | May 20, 2021 | Block Timothy M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 18, 2021 | May 20, 2021 | ADAMS THOMAS PHD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2021 | Feb 18, 2021 | Wijngaard Peter | Director | Buy | 91.3 | +10,000 | 50.00% | ✗ | $22K |
| Feb 18, 2021 | Feb 18, 2021 | Foster Robert T | CEO | Buy | 91.3 | +20,000 | 79.18% | ✗ | $40K |
| Feb 18, 2021 | Feb 18, 2021 | Cavan John T | CFO | Buy | 91.3 | +10,000 | 208.33% | ✗ | $20K |
| Dec 18, 2020 | Dec 21, 2020 | Wijngaard Peter | Director | Buy | 91.3 | +20,000 | 100.00% | ✗ | $38.2K |
| Dec 8, 2020 | Dec 8, 2020 | Foster Robert T | CEO | Buy | 91.3 | +25,000 | 9652.51% | ✗ | $39.4K |
| Dec 2, 2020 | Dec 2, 2020 | BRANCACCIO JOHN P | Director | Buy | 91.3 | +7,000 | 87500.00% | ✗ | $10.7K |
| Dec 1, 2020 | Dec 1, 2020 | JACOB GARY S | Director | Buy | 91.3 | +12,000 | 20338.98% | ✗ | $19.9K |
| Nov 25, 2020 | Nov 30, 2020 | Cavan John T | CFO | Buy | 90.0 | +4,500 | 1500.00% | ✗ | $7.3K |
| Aug 19, 2020 | Aug 21, 2020 | Foster Robert T | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 19, 2020 | Aug 21, 2020 | Lippa Arnold | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 19, 2020 | Aug 21, 2020 | Block Timothy M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 19, 2020 | Aug 21, 2020 | ADAMS THOMAS PHD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 19, 2020 | Aug 21, 2020 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 19, 2020 | Aug 21, 2020 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 19, 2020 | Aug 21, 2020 | Wijngaard Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 19, 2020 | Aug 21, 2020 | Cavan John T | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 25, 2020 | Jun 25, 2020 | Wijngaard Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 25, 2020 | Wijngaard Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | Apr 7, 2020 | ADAMS THOMAS PHD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2020 | Apr 7, 2020 | Block Timothy M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2020 | Apr 7, 2020 | Lippa Arnold | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2020 | Apr 7, 2020 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2020 | Apr 7, 2020 | Foster Robert T | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2020 | Apr 7, 2020 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2020 | Apr 7, 2020 | Cavan John T | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 24, 2019 | Jul 25, 2019 | Cavan John T | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 24, 2019 | Jul 25, 2019 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 24, 2019 | Jul 25, 2019 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 24, 2019 | Jul 25, 2019 | Block Timothy M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 24, 2019 | Jul 25, 2019 | ADAMS THOMAS PHD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 24, 2019 | Jul 25, 2019 | Lippa Arnold | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 24, 2019 | Jul 25, 2019 | Foster Robert T | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 2, 2019 | Garlikov Donald E | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 3, 2018 | Jul 3, 2018 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 3, 2018 | Jul 3, 2018 | Cavan John T | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 3, 2018 | Jul 3, 2018 | Lippa Arnold | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 3, 2018 | Jul 3, 2018 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2018 | Jan 5, 2018 | Cavan John T | CFO | Neutral | 90.0 | +101,221 | 151.70% | ✗ | - |
| Jan 3, 2018 | Jan 5, 2018 | SAPIRSTEIN JAMES | CEO | Neutral | 90.0 | +322,092 | 188.66% | ✗ | - |
| Jan 3, 2018 | Jan 5, 2018 | Foster Robert T | Chief Scientific Officer | Neutral | 90.0 | +100,654 | 228.33% | ✗ | - |
| Jul 20, 2017 | Jul 21, 2017 | Cavan John T | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 6, 2017 | Jul 7, 2017 | Cavan John T | CFO | Neutral | 90.0 | +46,726 | 233.63% | ✗ | - |
| Jul 6, 2017 | Jul 7, 2017 | SAPIRSTEIN JAMES | CEO | Neutral | 90.0 | +141,061 | 475.50% | ✗ | - |
| Jul 6, 2017 | Jul 7, 2017 | Sullivan-Bolyai John Z | Chief Medical Officer | Neutral | 90.0 | +58,681 | 100.00% | ✗ | - |
| Jul 6, 2017 | Jul 7, 2017 | Foster Robert T | Chief Scientific Officer | Neutral | 90.0 | +44,082 | 100.00% | ✗ | - |
| Jun 20, 2017 | Jun 22, 2017 | Cavan John T | CFO | Buy | 91.3 | +20,000 | 100.00% | ✗ | $13K |
| Apr 10, 2017 | Apr 11, 2017 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 3, 2017 | Mar 7, 2017 | SAPIRSTEIN JAMES | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 15, 2016 | HOWSON TAMAR D | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 27, 2016 | Oct 31, 2016 | SAPIRSTEIN JAMES | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 21, 2016 | ADAMS THOMAS PHD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Aug 26, 2016 | Aug 29, 2016 | Sullivan-Bolyai John Z | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 26, 2016 | Aug 29, 2016 | Cavan John T | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 17, 2016 | CERRONE GABRIEL | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 19, 2016 | Jul 20, 2016 | Lippa Arnold | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 19, 2016 | Jul 20, 2016 | Block Timothy M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 19, 2016 | Jul 20, 2016 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 19, 2016 | Jul 20, 2016 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 16, 2016 | Foster Robert T | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 13, 2016 | Jun 14, 2016 | Sullivan-Bolyai John Z | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 13, 2016 | Jun 14, 2016 | SAPIRSTEIN JAMES | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 20, 2016 | Cavan John T | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 2, 2016 | Sullivan-Bolyai John Z | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 18, 2016 | Feb 18, 2016 | SAPIRSTEIN JAMES | CEO | Buy | 91.3 | +10,000 | 333.33% | ✗ | $10K |
| Dec 3, 2015 | Lippa Arnold | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 30, 2015 | Dec 1, 2015 | SAPIRSTEIN JAMES | CEO | Buy | 90.0 | +500 | 20.00% | ✗ | $1.1K |
| Nov 23, 2015 | Nov 24, 2015 | SAPIRSTEIN JAMES | CEO | Buy | 90.0 | +2,500 | 100.00% | ✗ | $4.1K |
| Jun 4, 2015 | Jun 8, 2015 | Hornung William Karl | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 4, 2015 | Jun 8, 2015 | SAPIRSTEIN JAMES | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 3, 2014 | Dec 4, 2014 | SAPIRSTEIN JAMES | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 3, 2014 | Dec 4, 2014 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 3, 2014 | Dec 4, 2014 | McGuigan Christopher | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 3, 2014 | Dec 4, 2014 | Block Timothy M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 3, 2014 | Dec 4, 2014 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 3, 2014 | Dec 4, 2014 | Hornung William Karl | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2014 | Hornung William Karl | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2014 | Apr 4, 2014 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2014 | Apr 4, 2014 | Block Timothy M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2014 | Apr 4, 2014 | Denoyer Bernard | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 20, 2014 | SAPIRSTEIN JAMES | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |